KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to -$35.3 million.

  • Vertex Pharmaceuticals' Change in Account Payables fell 15340.39% to -$35.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year decrease of 2580.65%. This contributed to the annual value of $49.5 million for FY2024, which is 164.27% up from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Change in Account Payables stood at -$35.3 million, which was down 15340.39% from $7.6 million recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Change in Account Payables peaked at $159.9 million during Q4 2022, and registered a low of -$69.9 million during Q3 2022.
  • In the last 5 years, Vertex Pharmaceuticals' Change in Account Payables had a median value of $7.6 million in 2025 and averaged $13.1 million.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Change in Account Payables crashed by 342524.27% in 2021, and later surged by 2610000.0% in 2025.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Change in Account Payables stood at $53.9 million in 2021, then surged by 196.66% to $159.9 million in 2022, then crashed by 119.89% to -$31.8 million in 2023, then surged by 126.42% to $8.4 million in 2024, then tumbled by 520.24% to -$35.3 million in 2025.
  • Its Change in Account Payables stands at -$35.3 million for Q3 2025, versus $7.6 million for Q2 2025 and $26.2 million for Q1 2025.